Shanghai Fosun Pharmaceutical (Group) Co Ltd 2011 SR
The report highlights Fosun Pharma's 2011 sustainability efforts, focusing on R&D innovation, product quality, and environmental protection. The company invested 310 million RMB in R&D and expanded its presence in vaccines and medical services. Key environmental achievements include 16 member manufacturers passing cleaner production audits and significant investments in energy-saving technologies. Socially, the company continued its Future Star public welfare program, supporting education and anti-malaria efforts in Africa. The report also details the implementation of an EHS management system and adherence to GRI G3.1 guidelines with external assurance.
Company: Shanghai Fosun Pharmaceutical (Group) Co Ltd
Sector: Manufacturing
Country: China
Year: 2011
Type: SR
Pages: 88
Shanghai Fosun Pharmaceutical (Group) Co Ltd
The report highlights Fosun Pharma's 2011 sustainability efforts, focusing on R&D innovation, product quality, and environmental protection. The company invested 310 million RMB in R&D and expanded its presence in vaccines and medical services. Key environmental achievements include 16 member manufacturers passing cleaner production audits and significant investments in energy-saving technologies. Socially, the company continued its Future Star public welfare program, supporting education and anti-malaria efforts in Africa. The report also details the implementation of an EHS management system and adherence to GRI G3.1 guidelines with external assurance.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2011
Reporting Period
Jan 1, 2011 - Dec 31, 2011
Fiscal Year
2011
Published
Mar 23, 2012
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Workplace Fatalities
Employees